Sanofi Appoints Former GSK Executive Christopher Corsico as Global Head of Development
Sanofi
Pharmaceutical Manufacturer
GSK
Pharmaceutical R&D Manufacturer
Note:This article does not constitute any investment opinions or suggestions; please refer to official/company announcements for accuracy.This article is only for the introduction of medical and health-related drugs, not a recommendation of treatment plans (if involved), and does not represent the platform's position.Any article reprinted needs to be authorized.
April 1,Sanofi announces that Dr. Christopher Corsico has leftGSK(GSK), becoming its Global Development Director,Report to Dr. Houman Ashrafian, Executive Vice President of R&D at Sanofi, effective immediately.
Christopher Corsico, M.D.
Before joining Sanofi, Corsico served as Senior Vice President and Global Head of Development at GSK for more than six years. He alsoBoehringer IngelheimThe company has worked for more than 20 years, serving as the Chief Medical Officer.
AndDietmar Berger, Ph.D., former Global Head of R&D and Chief Medical Officer (CMO) of Sanofi, wasGilead Sciences(Gilead Sciences) poached.
Copyright statement: This article is reproduced from Pharma Mastery，Media or individuals who do not wish to be reproduced can contact us, and we will delete it immediately.
'%20fill='%23FFFFFF'%3E%3Crect%20x='249'%20y='126'%20width='1'%20height='1'%3E%3C/rect%3E%3C/g%3E%3C/g%3E%3C/svg%3E)
Rooted in Shanghai and radiating globally, PharmaCircle, as a strategic platform for the biopharmaceutical industry, is committed to the mission of "enabling the borderless flow of intelligence and networks." It has built an all-encompassing industrial chain empowerment system covering drug R&D, production, distribution, and commercialization. Through four core engines—intelligent cloud services, precise resource connections, industrial think tanks, and ecosystem communities—it establishes the infrastructure for the flow of pharmaceutical value in China.
Under the dual waves of globalization and digitalization, PharmaCircle is redefining the circulation paradigm of pharmaceutical resources—this is not only a hub for information and networking but also a catalyst for industrial transformation. With China as the origin, we weave a global network of pharmaceutical intelligence, making every precise connection a catalyst for enterprises' leapfrog growth.